Medication interaction study for healthy adults
Treatments studied
This trial studies how a new tablet called Y-4 interacts with pregabalin and riluzole in healthy people. It helps doctors understand how these drugs work together in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Healthy adults aged 18 to 45
- Weigh at least 50 kg (men) or 45 kg (women), with a BMI between 19 and 28
- Normal kidney function, as measured by a blood test
- No allergies to any of the medications or ingredients used in the study
- Able to follow a strict diet and avoid caffeine, alcohol, smoking, and certain foods like grapefruit
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how food affects the way a new medicine (Y-4 tablet) is processed in the body. It is looking for healthy volunteers to take a single dose of the study drug and have their blood levels checked over time.
This early-phase study tests how a new medicine (Y-4) moves through the body when taken with two other drugs (pregabalin and riluzole) in healthy people. It helps doctors understand the safety and dosing before testing in patients.
This trial tests the safety and how the body processes a new medicine called Y-4. Healthy adults ages 18 to 45 can join to help researchers understand how the drug works and if it has any side effects.
This trial tests a new tablet drug in healthy people to see how safe it is and how the body processes it. It is an early-stage study, meaning it helps find the right dose and check for side effects.
This trial tests a new drug called Y-4 for people with lingering nerve pain after shingles (postherpetic neuralgia). If you have had pain for more than a month after your rash healed, this study may help find a new treatment option.
This study tests a new tablet in healthy adults to see how the body processes it and whether food changes its effects. It helps determine the right dose and safety for future patients.
Hear when a new Healthy Male and Female Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.